Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF

被引：0
|
作者：
Yanai, H. [1 ,2 ]
Amir, S. [2 ]
Biron, I. Avni [1 ,2 ]
Perets, T. Tsadok [1 ,2 ]
Shamir, R. [2 ,3 ]
Dotan, I. [1 ,2 ]
Assa, A. [2 ,3 ]
机构：
[1] Rabin Med Ctr, IBD Ctr, Div Gastroenterol, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Schneider Childrens Med Ctr, Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P506
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [41] Treatment of Kawasaki disease with anti-TNF antibodies
    Levin, Michael
    Burgner, David
    LANCET, 2014, 383 (9930): : 1700 - 1703
  • [42] Audit of anti-TNFα antibodies in clinical practice
    Arnott, IDR
    McDonald, D
    Williams, A
    Ghosh, S
    GUT, 2001, 48 : A19 - A20
  • [43] Innate anti-TNFα antibodies that neutralize TNFα are found in patients who are subsequent nonresponders to infliximab
    Ebert, Ellen C.
    Das, Kiron M.
    Mithani, Sima
    GASTROENTEROLOGY, 2008, 134 (04) : A648 - A648
  • [44] Transmembrane TNF-dependent uptake of anti-TNF antibodies
    Deora, Arun
    Hegde, Subramanya
    Lee, Jacqueline
    Choi, Chee-Ho
    Chang, Qing
    Lee, Cheryl
    Eaton, Lucia
    Tang, Hua
    Wang, Dongdong
    Lee, David
    Michalak, Mark
    Tomlinson, Medha
    Tao, Qingfeng
    Gaur, Nidhi
    Harvey, Bohdan
    McLoughlin, Shaun
    Labkovsky, Boris
    Ghayur, Tariq
    MABS, 2017, 9 (04) : 680 - 695
  • [45] Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab
    Yanai, Henit
    Lichtenstein, Lev
    Assa, Amit
    Mazor, Yoav
    Weiss, Batia
    Levine, Arie
    Ron, Yulia
    Kopylov, Uri
    Bujanover, Yoram
    Rosenbach, Yoram
    Ungar, Bella
    Eliakim, Abraham R.
    Chowers, Yehuda
    Shamir, Raanan
    Fraser, Gerald
    Dotan, Iris
    Ben-Horin, Shomron
    GASTROENTEROLOGY, 2014, 146 (05) : S381 - S381
  • [46] REVERSAL OF ANTI-DRUG ANTIBODIES TO ANTI-TNF THERAPY WITH ADDITION OF IMMUNOMODULATORS: A SYSTEMIC REVIEW AND META-ANALYSIS
    Kucharski, Kimberly
    Kashani, Amir
    GASTROENTEROLOGY, 2023, 164 (06) : S655 - S655
  • [47] Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model
    Bhol, Kailash
    Erlich, Emma
    Lemos, Brenda
    Tracey, Daniel
    Hartman, Deborah
    Fox, Barbara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S545 - S546
  • [48] Older Adults Are at Higher Risk for Developing Anti-TNF Antibodies
    Faye, Adam
    Hong, Simon
    Axelrad, Jordan
    Katz, Seymour
    Hudesman, David
    Dervieux, Thierry
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S703 - S703
  • [49] Higher body mass index and anti-drug antibodies predict the discontinuation of anti-TNF agents in Korean patients with axial spondyloarthritis
    Hwang, Jiwon
    Kim, Hye-Mi
    Jeong, Hyemin
    Lee, Jaejoon
    Ahn, Joong Kyong
    Koh, Eun-Mi
    Kang, Eun-Suk
    Cha, Hoon-Suk
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2017, 57 (04) : 311 - 319
  • [50] HLA-DQA1*05 and development of anti-drug antibodies in anti-TNF treated patients with inflammatory bowel disease
    Lopez-Blanco, Ruben
    Mendez-Lopez, Isabel-Maria
    Recio-Romero, Rafael
    Luque-Fernandez, Rosario
    Caballero-Gonzalez, Abelardo
    Torio-Ruiz, Alberto
    HLA, 2022, 99 (05) : 539 - 540
12345